Vireo Growth Inc. (VREOF) stock
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $406.23MP/E –Yield –
Vireo Growth price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Vireo Growth's price to sales ratio was 0.7× on Oct 19, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.2× to 5.0×, with a median of 0.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.7× | −1.1 |
| 2025 | Dec 31, 2025 | 1.7× | +0.8 |
| 2024 | Dec 31, 2024 | 0.9× | +0.5 |
| 2023 | Dec 29, 2023 | 0.4× | +0.1 |
| 2022 | Dec 30, 2022 | 0.3× | −3.5 |
| 2021 | Dec 31, 2021 | 3.8× | – |
See a number that looks wrong?